Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study	Chemically-Induced Disorders, Stress Disorders, Traumatic, acute stress disorder, alcohol-related disorders, post-traumatic stress disorder, psychiatric disorder, substance-related disorder	Recruiting	Phase 1	2026-09-21		NCT06335407

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioXcel Therapeutics Inc	4
Congressionally Directed Medical Research Programs	87
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance	3
RTI International	51
United States Department of Defense	319
VA Connecticut Healthcare System	13
Yale University	458

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
VA Connecticut Healthcare System	West Haven	United States	12